News

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...
Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...
Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.
A woman is speaking out after her successful attempt to buy weight-loss drug Mounjaro by using a ‘before’ image of another ...
China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...
The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
West Pharmaceutical (NYSE:WST) surges after Q2 results beat estimates & full-year guidance rises. Read more here.
GLP-1 agonists and dual agonists can cause hypoglycemia, nausea, and more. But there are ways to lessen the side effects, so you can keep taking the medication.
CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...